| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.42 | 7e-12 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |